Alkem Laboratories P/B Ratio

Current P/B Ratio
4.42
High Valuation
Very High - Significant premium, high growth expectations or speculative

Alkem Laboratories (ALKEM) P/B ratio is 4.42 (High), book value per share ₹5978.75 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. Explore ALKEM value investing to estimate fundamental worth using multiple valuation models.

Current Valuation Metrics

P/B Ratio 4.42
Current Price ₹5466.50
Book Value/Share ₹5978.75
Exchange NSE

Book Value Breakdown (2026)

Balance Sheet Components
Total Equity ₹14,349 Cr
Share Capital ₹24 Cr
Reserves & Surplus ₹13,796 Cr
Outstanding Shares 24,000,000
Book Value per Share ₹5978.75

Valuation Signal

Signal Overvalued
Historical Avg 1.07
Historical Range 0.82 - 1.32
Percentile 100.0%

Sector Context

Sector Average -0.01
Sector Median 0.62
Sector Rank #11 of 50
Sector Percentile 22.0%

ALKEM P/B Ratio — Valuation Insights & Book Value Analysis

Alkem Laboratories price-to-book ratio interpretation, valuation status and historical context — current P/B 4.42 (High). Read ALKEM dividend track record for the complete payout history and dividend yield track record.

  • Stock appears overvalued with PB of 4.42, trading at significant premium to book value
  • Trading at high premium to book value - indicates strong growth expectations or asset-light business model
  • Current PB is 311.5% above historical average
  • Trading at premium to sector average PB of -0.01

Alkem Laboratories P/B Ratio Historical Trend

ALKEM annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see ALKEM share price.

ALKEM Historical P/B Ratio — Book Value Per Share & Year-End Price

Alkem Laboratories annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2026 0.91 ₹5978.75 ₹5466.50 ₹14,349 Low
2025 1.06 ₹5180.83 ₹5506.50 ₹12,434 Moderate
2024 1.26 ₹4464.17 ₹5633.90 ₹10,714 Moderate
2023 1.32 ₹3931.25 ₹5202.60 ₹9,435 Moderate
2022 0.82 ₹3686.25 ₹3004.70 ₹8,847 Low

ALKEM vs Healthcare Peers — P/B Ratio Comparison

Alkem Laboratories P/B 4.42 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.

Sector Average
-0.01
Sector Median
0.62
Lowest P/B
-6.55
Highest P/B
1.09
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Parmax Pharma PARMAX -6.55 ₹46 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.0 ₹65 Low
Krebs Biochemicals & Ind… KREBSBIO -0.82 ₹129 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.21 ₹50 Low
Triochem Products TRIPR 0.04 ₹0 Low